HomeCompareVYNT vs EPRT

VYNT vs EPRT: Dividend Comparison 2026

VYNT yields 1030.93% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VYNT wins by $24587954.13M in total portfolio value
10 years
VYNT
VYNT
● Live price
1030.93%
Share price
$0.19
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24587954.20M
Annual income
$20,648,027,961,236.51
Full VYNT calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — VYNT vs EPRT

📍 VYNT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVYNTEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VYNT + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VYNT pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VYNT
Annual income on $10K today (after 15% tax)
$87,628.87/yr
After 10yr DRIP, annual income (after tax)
$17,550,823,767,051.04/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, VYNT beats the other by $17,550,823,756,136.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VYNT + EPRT for your $10,000?

VYNT: 50%EPRT: 50%
100% EPRT50/50100% VYNT
Portfolio after 10yr
$12293977.13M
Annual income
$10,324,013,987,038.61/yr
Blended yield
83.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

VYNT
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-12.0
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VYNT buys
0
EPRT buys
0
No recent congressional trades found for VYNT or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVYNTEPRT
Forward yield1030.93%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$24587954.20M$63.4K
Annual income after 10y$20,648,027,961,236.51$12,840.73
Total dividends collected$24288183.04M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: VYNT vs EPRT ($10,000, DRIP)

YearVYNT PortfolioVYNT Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$113,793$103,092.78$11,205$505.18+$102.6KVYNT
2$1,218,133$1,096,375.21$12,672$682.46+$1.21MVYNT
3$12,272,114$10,968,711.02$14,490$930.48+$12.26MVYNT
4$116,406,425$103,275,262.74$16,786$1,282.69+$116.39MVYNT
5$1,040,079,657$915,524,782.99$19,753$1,791.56+$1040.06MVYNT
6$8,757,858,648$7,644,973,414.41$23,677$2,541.64+$8757.83MVYNT
7$69,533,084,085$60,162,175,331.66$29,008$3,672.99+$69533.06MVYNT
8$520,809,783,127$446,409,383,156.47$36,463$5,425.08+$520809.75MVYNT
9$3,682,174,050,693$3,124,907,582,747.50$47,238$8,221.57+$3682174.00MVYNT
10$24,587,954,195,479$20,648,027,961,236.51$63,385$12,840.73+$24587954.13MVYNT

VYNT vs EPRT: Complete Analysis 2026

VYNTStock

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.

Full VYNT Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this VYNT vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VYNT vs SCHDVYNT vs JEPIVYNT vs OVYNT vs KOVYNT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.